Pennsylvania's Puberty Blockers: Fraud and Accountability Needed
Submitted by MAGA
Posted 4 hours ago
Unbelievable.
Newly unearthed data from Pennsylvania reveals a shocking surge in the number of adolescents receiving puberty blockers, raising serious questions about potential fraud.
From 2013 to 2024, over 220 claims for puberty-blocking drugs were reimbursed for minors aged 10 to 13 under an insurance billing code currently under investigation by the Department of Justice.
The cost to taxpayers? A staggering $1.8 million.
Before 2013, the number of claims for puberty blockers in this age group sat at zero, only to balloon to 47 claims by 2016. This dramatic spike has caught the attention of medical professionals and the Justice Department, who are now looking into the potential misuse of billing codes by gender clinics.
Dr. Kurt Miceli, a medical director at Do No Harm, pointed out the unlikely nature of such a sudden increase in diagnoses for precocious puberty, suggesting it could be an inappropriate workaround for gender-related interventions.
Other experts have echoed these concerns. Dr. Roy Eappen noted that it would be "very, very rare" for children over the age of 10 to be diagnosed with precocious puberty, emphasizing that most appropriate cases are identified in much younger patients.
The ongoing investigation into Pennsylvania's gender clinics has raised alarm bells not only in the state but nationwide, as more than 20 providers, including prominent hospitals, have been subpoenaed.
The reality is clear: some medical practices appear to be misusing programming meant to address actual medical conditions to advance a controversial agenda around gender identity.
Furthermore, the recent past has shown that the current administration not only allows but appears to encourage practices that blur the lines of medical ethics and children’s rights.
In response to these alarming practices, Texas Attorney General Ken Paxton has taken a firm stance, alleging fraudulent activities linked to Medicaid reimbursements for puberty blockers, demanding accountability and stricter enforcement of existing laws.
The evidence continues to stack up. A mind-boggling 2100% increase in insurance reimbursements for puberty blockers between 2013 and 2017 is hard to ignore, raising important ethical questions about the treatment of minors.
As these investigations unfold, it’s crucial for Americans to remain vigilant and demand transparency in how taxpayer dollars are being spent in the medical community.
In what should be an era of accountability, it’s clear that this situation warrants immediate scrutiny to protect our children and uphold the integrity of medical practices.
Sources:
dailycallernewsfoundation.org
thegatewaypundit.com
harbingersdaily.com
Newly unearthed data from Pennsylvania reveals a shocking surge in the number of adolescents receiving puberty blockers, raising serious questions about potential fraud.
From 2013 to 2024, over 220 claims for puberty-blocking drugs were reimbursed for minors aged 10 to 13 under an insurance billing code currently under investigation by the Department of Justice.
The cost to taxpayers? A staggering $1.8 million.
Before 2013, the number of claims for puberty blockers in this age group sat at zero, only to balloon to 47 claims by 2016. This dramatic spike has caught the attention of medical professionals and the Justice Department, who are now looking into the potential misuse of billing codes by gender clinics.
Dr. Kurt Miceli, a medical director at Do No Harm, pointed out the unlikely nature of such a sudden increase in diagnoses for precocious puberty, suggesting it could be an inappropriate workaround for gender-related interventions.
Other experts have echoed these concerns. Dr. Roy Eappen noted that it would be "very, very rare" for children over the age of 10 to be diagnosed with precocious puberty, emphasizing that most appropriate cases are identified in much younger patients.
The ongoing investigation into Pennsylvania's gender clinics has raised alarm bells not only in the state but nationwide, as more than 20 providers, including prominent hospitals, have been subpoenaed.
The reality is clear: some medical practices appear to be misusing programming meant to address actual medical conditions to advance a controversial agenda around gender identity.
Furthermore, the recent past has shown that the current administration not only allows but appears to encourage practices that blur the lines of medical ethics and children’s rights.
In response to these alarming practices, Texas Attorney General Ken Paxton has taken a firm stance, alleging fraudulent activities linked to Medicaid reimbursements for puberty blockers, demanding accountability and stricter enforcement of existing laws.
The evidence continues to stack up. A mind-boggling 2100% increase in insurance reimbursements for puberty blockers between 2013 and 2017 is hard to ignore, raising important ethical questions about the treatment of minors.
As these investigations unfold, it’s crucial for Americans to remain vigilant and demand transparency in how taxpayer dollars are being spent in the medical community.
In what should be an era of accountability, it’s clear that this situation warrants immediate scrutiny to protect our children and uphold the integrity of medical practices.
Sources:
dailycallernewsfoundation.org
thegatewaypundit.com
harbingersdaily.com
Latest News